Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2010 16:00 ET | Source: Athersys, Inc.

Athersys Reports Fourth Quarter and 2009 Annual Results

CLEVELAND, March 11, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter of 2009 and for the year ended December 31, 2009. Fourth...
February 25, 2010 16:00 ET | Source: Athersys, Inc.

Athersys to Host Fourth Quarter Financial Results Call

CLEVELAND, Feb. 25, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its fourth quarter 2009 financial results at approximately 4:00 PM (Eastern Time) on Thursday,...
February 16, 2010 06:30 ET | Source: Athersys, Inc.

Athersys Announces Completion of Patient Enrollment in Phase I Study of Multistem(R) in Acute Myocardial Infarction

CLEVELAND, Feb. 16, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced that it has completed patient enrollment for its phase I clinical trial of MultiStem®, its allogeneic...
February 10, 2010 06:30 ET | Source: Athersys, Inc.

Athersys Receives U.S. Patent Covering Adult Stem Cell Composition & Production

CLEVELAND, Feb. 10, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has been granted U.S. patent 7,659,118 that covers non-embryonic multipotent stem cells, their...
February 02, 2010 11:00 ET | Source: Athersys, Inc.

Athersys to Present at 12th Annual BIO CEO & Investor Conference

CLEVELAND, Feb. 2, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it will present at the 12th Annual BIO CEO & Investor Conference to be held at the Waldorf-Astoria...
January 14, 2010 16:30 ET | Source: Athersys, Inc.

Athersys Files Shelf Registration Statement

CLEVELAND, Jan. 14, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has filed a shelf registration statement with the Securities and Exchange Commission ("SEC"). Athersys...
December 21, 2009 06:00 ET | Source: Athersys, Inc.

Athersys Enters Into Global Agreement With Pfizer to Develop and Market MultiStem(R) for the Treatment of Inflammatory Bowel Disease

CLEVELAND, Dec. 21, 2009 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has entered into an agreement with Pfizer Inc. (PFE) to develop and commercialize MultiStem(R) for the...
November 05, 2009 16:00 ET | Source: Athersys, Inc.

Athersys Reports 2009 Third Quarter Results

CLEVELAND, Nov. 5, 2009 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the quarter ended September 30, 2009. Third Quarter Highlights Include: *...
October 20, 2009 11:00 ET | Source: Athersys, Inc.

Athersys to Host Third Quarter 2009 Financial Results Call

CLEVELAND, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will release its third quarter 2009 financial results at approximately 4:00 PM (Eastern Time) on Thursday,...
August 06, 2009 16:00 ET | Source: Athersys, Inc.

Athersys Reports 2009 Second Quarter Results

CLEVELAND, Aug. 6, 2009 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the quarter ended June 30, 2009. Second Quarter Highlights Include: Continued ...